Brentuximab Vedotin for Hodgkin’s Lymphoma
March 19, 2024
Article:
N Engl J Med. 2022 Nov 3;387(18):1649-1660.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma
Reviewer: Dr. Asba Memon
March 19, 2024
Article:
N Engl J Med. 2022 Nov 3;387(18):1649-1660.
Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma
Reviewer: Dr. Asba Memon